title: Effective control of bone pain by octreotide in a patient with metastatic gastrinoma.
authors.affiliation: Department of Diabetes and Endocrine Services, Royal Hobart Hospital, TAS.
authors.forename: J R
authors.initials: JR
authors.lastname: Burgess
authors.forename: J J
authors.initials: JJ
authors.lastname: Shepherd
authors.forename: F J
authors.initials: FJ
authors.lastname: Murton
authors.forename: V
authors.initials: V
authors.lastname: Parameswaran
authors.forename: T M
authors.initials: TM
authors.lastname: Greenaway
mesh_terms: D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D015408:Gastrinoma / Q000556:secondary*; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008875:Middle Aged; D018761:Multiple Endocrine Neoplasia Type 1 / Q000473:pathology / Q000628:therapy; D015282:Octreotide / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy*; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000473:pathology*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D006728:Hormones; D015282:Octreotide